GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Debt-to-EBITDA
中文

Olympus (Olympus) Debt-to-EBITDA : 1.49 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Olympus Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Olympus's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $555 Mil. Olympus's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,561 Mil. Olympus's annualized EBITDA for the quarter that ended in Dec. 2023 was $1,420 Mil. Olympus's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.49.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Olympus's Debt-to-EBITDA or its related term are showing as below:

OLYMY' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.32   Med: 2.14   Max: 5.6
Current: 2.04

During the past 13 years, the highest Debt-to-EBITDA Ratio of Olympus was 5.60. The lowest was 1.32. And the median was 2.14.

OLYMY's Debt-to-EBITDA is ranked worse than
62.56% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.225 vs OLYMY: 2.04

Olympus Debt-to-EBITDA Historical Data

The historical data trend for Olympus's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Debt-to-EBITDA Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.03 1.73 2.48 1.82 1.32

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 1.43 2.18 -128.11 1.49

Competitive Comparison of Olympus's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Olympus's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Olympus's Debt-to-EBITDA falls into.



Olympus Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Olympus's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(373.847 + 2170.265) / 1924.298
=1.32

Olympus's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(555.356 + 1560.742) / 1420.072
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Olympus  (OTCPK:OLYMY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Olympus Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Olympus's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (Olympus) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (Olympus) Headlines

From GuruFocus

David Herro Comments on Olympus Corp.

By Holly LaFon 04-23-2013

David Herro Comments on Olympus

By Vera Yuan Vera Yuan 10-07-2014

David Herro Comments on Olympus

By Holly LaFon Holly LaFon 10-10-2016

David Herro's Oakmark International Fund Q1 2013 Commentary

By Holly LaFon Holly LaFon 04-23-2013

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

By ACN Newswire ACN Newswire 12-05-2022